Auto - Dealerships
Compare Stocks
5 / 10Stock Comparison
CVNA vs VRM vs CPRT vs KMX vs ACVA
Revenue, margins, valuation, and 5-year total return — side by side.
Auto - Dealerships
Specialty Business Services
Auto - Dealerships
Auto - Dealerships
CVNA vs VRM vs CPRT vs KMX vs ACVA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Auto - Dealerships | Auto - Dealerships | Specialty Business Services | Auto - Dealerships | Auto - Dealerships |
| Market Cap | $82.19B | $67M | $32.07B | $5.33B | $935M |
| Revenue (TTM) | $22.52B | $3M | $4.61B | $27.38B | $760M |
| Net Income (TTM) | $1.60B | $-78M | $1.56B | $458M | $-66M |
| Gross Margin | 20.0% | -476.8% | 45.3% | 11.0% | 62.1% |
| Operating Margin | 9.2% | -60.9% | 36.5% | 1.7% | -8.3% |
| Forward P/E | 48.7x | — | 21.0x | 13.8x | 27.9x |
| Total Debt | $633M | $752M | $104M | $19.43B | $190M |
| Cash & Equiv. | $2.33B | $29M | $2.78B | $247M | $271M |
CVNA vs VRM vs CPRT vs KMX vs ACVA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Carvana Co. (CVNA) | 100 | 144.5 | +44.5% |
| Vroom, Inc. (VRM) | 100 | 0.4 | -99.6% |
| Copart, Inc. (CPRT) | 100 | 122.1 | +22.1% |
| CarMax, Inc. (KMX) | 100 | 28.1 | -71.9% |
| ACV Auctions Inc. (ACVA) | 100 | 15.6 | -84.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CVNA vs VRM vs CPRT vs KMX vs ACVA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CVNA is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 48.6%, EPS growth 431.4%, 3Y rev CAGR 14.3%
- 33.2% 10Y total return vs CPRT's 5.2%
- 48.6% revenue growth vs VRM's -98.7%
- +46.0% vs ACVA's -64.9%
VRM lags the leaders in this set but could rank higher in a more targeted comparison.
CPRT carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 0.52, Low D/E 1.1%, current ratio 8.25x
- Beta 0.52, current ratio 8.25x
- 33.8% margin vs VRM's -27.7%
- Beta 0.52 vs CVNA's 2.14, lower leverage
KMX ranks third and is worth considering specifically for income & stability.
- Dividend streak 1 yrs, beta 1.32
- Lower P/E (13.8x vs 21.0x)
Among these 5 stocks, ACVA doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 48.6% revenue growth vs VRM's -98.7% | |
| Value | Lower P/E (13.8x vs 21.0x) | |
| Quality / Margins | 33.8% margin vs VRM's -27.7% | |
| Stability / Safety | Beta 0.52 vs CVNA's 2.14, lower leverage | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +46.0% vs ACVA's -64.9% | |
| Efficiency (ROA) | 14.7% ROA vs VRM's -7.9%, ROIC 20.1% vs -10.0% |
CVNA vs VRM vs CPRT vs KMX vs ACVA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CVNA vs VRM vs CPRT vs KMX vs ACVA — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
KMX leads in 2 of 6 categories
CPRT leads 1 • CVNA leads 1 • VRM leads 0 • ACVA leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — VRM and CPRT each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
KMX is the larger business by revenue, generating $27.4B annually — 9699.3x VRM's $3M. CPRT is the more profitable business, keeping 33.8% of every revenue dollar as net income compared to VRM's -27.7%. On growth, CVNA holds the edge at +52.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $22.5B | $3M | $4.6B | $27.4B | $760M |
| EBITDAEarnings before interest/tax | $2.3B | -$162M | $1.9B | $791M | -$19M |
| Net IncomeAfter-tax profit | $1.6B | -$78M | $1.6B | $458M | -$66M |
| Free Cash FlowCash after capex | $740M | $25M | $1.4B | $1.9B | $51M |
| Gross MarginGross profit ÷ Revenue | +20.0% | -4.8% | +45.3% | +11.0% | +62.1% |
| Operating MarginEBIT ÷ Revenue | +9.2% | -60.9% | +36.5% | +1.7% | -8.3% |
| Net MarginNet income ÷ Revenue | +7.1% | -27.7% | +33.8% | +1.7% | -8.7% |
| FCF MarginFCF ÷ Revenue | +3.3% | +9.0% | +30.5% | +7.1% | +6.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +52.0% | -100.2% | -3.6% | -13.4% | +15.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +11.9% | +76.6% | -10.0% | -46.9% | +31.3% |
Valuation Metrics
KMX leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 11.6x trailing earnings, KMX trades at a 74% valuation discount to CVNA's 44.9x P/E. On an enterprise value basis, CPRT's 15.4x EV/EBITDA is more attractive than CVNA's 37.3x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $82.2B | $67M | $32.1B | $5.3B | $935M |
| Enterprise ValueMkt cap + debt − cash | $80.5B | $790M | $29.4B | $24.5B | $854M |
| Trailing P/EPrice ÷ TTM EPS | 44.86x | -0.14x | 20.85x | 11.60x | -13.85x |
| Forward P/EPrice ÷ next-FY EPS est. | 48.69x | — | 21.04x | 13.83x | 27.94x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.24x | — | — |
| EV / EBITDAEnterprise value multiple | 37.33x | — | 15.37x | 22.26x | — |
| Price / SalesMarket cap ÷ Revenue | 4.04x | 5.77x | 6.90x | 0.19x | 1.23x |
| Price / BookPrice ÷ Book value/share | 20.23x | — | 3.52x | 0.93x | 2.14x |
| Price / FCFMarket cap ÷ FCF | 92.45x | — | 26.06x | 34.05x | 13.53x |
Profitability & Efficiency
CPRT leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CVNA delivers a 45.9% return on equity — every $100 of shareholder capital generates $46 in annual profit, vs $-77 for VRM. CPRT carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to KMX's 3.11x. On the Piotroski fundamental quality scale (0–9), KMX scores 8/9 vs VRM's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +45.9% | -77.0% | +15.9% | +7.5% | -15.4% |
| ROA (TTM)Return on assets | +13.8% | -7.9% | +14.7% | +1.8% | -6.1% |
| ROICReturn on invested capital | +34.3% | -10.0% | +20.1% | +2.4% | -13.5% |
| ROCEReturn on capital employed | +20.0% | -19.4% | +19.7% | +3.1% | -9.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 6 | 8 | 6 |
| Debt / EquityFinancial leverage | 0.15x | — | 0.01x | 3.11x | 0.44x |
| Net DebtTotal debt minus cash | -$1.7B | $723M | -$2.7B | $19.2B | -$81M |
| Cash & Equiv.Liquid assets | $2.3B | $29M | $2.8B | $247M | $271M |
| Total DebtShort + long-term debt | $633M | $752M | $104M | $19.4B | $190M |
| Interest CoverageEBIT ÷ Interest expense | -0.68x | -0.54x | — | 3.08x | -5.74x |
Total Returns (Dividends Reinvested)
CVNA leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CVNA five years ago would be worth $13,509 today (with dividends reinvested), compared to $36 for VRM. Over the past 12 months, CVNA leads with a +46.0% total return vs ACVA's -64.9%. The 3-year compound annual growth rate (CAGR) favors CVNA at 2.5% vs VRM's -42.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -5.3% | -38.1% | -12.2% | -5.2% | -34.9% |
| 1-Year ReturnPast 12 months | +46.0% | -50.6% | -45.7% | -43.8% | -64.9% |
| 3-Year ReturnCumulative with dividends | +4130.9% | -80.7% | -16.0% | -47.2% | -60.7% |
| 5-Year ReturnCumulative with dividends | +35.1% | -99.6% | +8.2% | -73.0% | -83.9% |
| 10-Year ReturnCumulative with dividends | +3315.2% | -99.7% | +516.2% | -26.4% | -82.7% |
| CAGR (3Y)Annualised 3-year return | +2.5% | -42.2% | -5.6% | -19.2% | -26.7% |
Risk & Volatility
Evenly matched — CVNA and CPRT each lead in 1 of 2 comparable metrics.
Risk & Volatility
CPRT is the less volatile stock with a 0.52 beta — it tends to amplify market swings less than CVNA's 2.14 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVNA currently trades 77.9% from its 52-week high vs ACVA's 30.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.14x | 1.85x | 0.52x | 1.32x | 1.33x |
| 52-Week HighHighest price in past year | $486.89 | $34.99 | $63.85 | $71.99 | $17.54 |
| 52-Week LowLowest price in past year | $253.49 | $9.04 | $32.20 | $30.26 | $4.07 |
| % of 52W HighCurrent price vs 52-week peak | +77.9% | +36.8% | +51.9% | +51.7% | +30.8% |
| RSI (14)Momentum oscillator 0–100 | 52.5 | 39.4 | 45.3 | 36.5 | 59.2 |
| Avg Volume (50D)Average daily shares traded | 2.7M | 14K | 8.1M | 3.2M | 3.0M |
Analyst Outlook
KMX leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: CVNA as "Hold", CPRT as "Buy", KMX as "Hold", ACVA as "Buy". Consensus price targets imply 66.7% upside for ACVA (target: $9) vs 1.4% for KMX (target: $38).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | — | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $484.00 | — | $40.50 | $37.78 | $9.00 |
| # AnalystsCovering analysts | 44 | — | 19 | 35 | 17 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | — | — | 1 | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +8.0% | 0.0% |
KMX leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). CPRT leads in 1 (Profitability & Efficiency). 2 tied.
CVNA vs VRM vs CPRT vs KMX vs ACVA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CVNA or VRM or CPRT or KMX or ACVA a better buy right now?
For growth investors, Carvana Co.
(CVNA) is the stronger pick with 48. 6% revenue growth year-over-year, versus -98. 7% for Vroom, Inc. (VRM). CarMax, Inc. (KMX) offers the better valuation at 11. 6x trailing P/E (13. 8x forward), making it the more compelling value choice. Analysts rate Copart, Inc. (CPRT) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CVNA or VRM or CPRT or KMX or ACVA?
On trailing P/E, CarMax, Inc.
(KMX) is the cheapest at 11. 6x versus Carvana Co. at 44. 9x. On forward P/E, CarMax, Inc. is actually cheaper at 13. 8x.
03Which is the better long-term investment — CVNA or VRM or CPRT or KMX or ACVA?
Over the past 5 years, Carvana Co.
(CVNA) delivered a total return of +35. 1%, compared to -99. 6% for Vroom, Inc. (VRM). Over 10 years, the gap is even starker: CVNA returned +33. 2% versus VRM's -99. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CVNA or VRM or CPRT or KMX or ACVA?
By beta (market sensitivity over 5 years), Copart, Inc.
(CPRT) is the lower-risk stock at 0. 52β versus Carvana Co. 's 2. 14β — meaning CVNA is approximately 312% more volatile than CPRT relative to the S&P 500. On balance sheet safety, Copart, Inc. (CPRT) carries a lower debt/equity ratio of 1% versus 3% for CarMax, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CVNA or VRM or CPRT or KMX or ACVA?
By revenue growth (latest reported year), Carvana Co.
(CVNA) is pulling ahead at 48. 6% versus -98. 7% for Vroom, Inc. (VRM). On earnings-per-share growth, the picture is similar: Carvana Co. grew EPS 431. 4% year-over-year, compared to 6. 3% for CarMax, Inc.. Over a 3-year CAGR, ACVA leads at 21. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CVNA or VRM or CPRT or KMX or ACVA?
Copart, Inc.
(CPRT) is the more profitable company, earning 33. 4% net margin versus -1422. 3% for Vroom, Inc. — meaning it keeps 33. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CPRT leads at 36. 5% versus -1092. 2% for VRM. At the gross margin level — before operating expenses — VRM leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CVNA or VRM or CPRT or KMX or ACVA more undervalued right now?
On forward earnings alone, CarMax, Inc.
(KMX) trades at 13. 8x forward P/E versus 48. 7x for Carvana Co. — 34. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ACVA: 66. 7% to $9. 00.
08Which pays a better dividend — CVNA or VRM or CPRT or KMX or ACVA?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is CVNA or VRM or CPRT or KMX or ACVA better for a retirement portfolio?
For long-horizon retirement investors, Copart, Inc.
(CPRT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 52), +516. 2% 10Y return). Carvana Co. (CVNA) carries a higher beta of 2. 14 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CPRT: +516. 2%, CVNA: +33. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CVNA and VRM and CPRT and KMX and ACVA?
These companies operate in different sectors (CVNA (Consumer Cyclical) and VRM (Consumer Cyclical) and CPRT (Industrials) and KMX (Consumer Cyclical) and ACVA (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CVNA is a mid-cap high-growth stock; VRM is a small-cap quality compounder stock; CPRT is a mid-cap quality compounder stock; KMX is a small-cap deep-value stock; ACVA is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.